2023 24 Hours of Lasers - Hour 21: Laser Scar Treatment - A Flash Behind the Scenes of Drug and Device Development
Session Director: Peter R. Shumaker, MD | VA San Diego Healthcare System, University of California, San Diego | San Diego, California
Speakers: Ray Choye; David Ozog, MD; Sunny Zhou, PhD
Moderators: Miranda An, Yingjoy Li, Ajay Sharma, MD
Hour 21: Laser Scar Treatment - A Flash Behind the Scenes of Drug and Device Development
Discussed Topics Include:
- efficacy of laser treatments for hypertrophic scars
- significance of clinical evidence in treatment decisions
- advocacy for patient access
Peter Shumaker, MD
Chief of Dermatology
VA San Diego
Peter Shumaker, MD, retired as a Captain in the United States Navy having spent more than a third of his 22 years of service as Chairman of the Department of Dermatology at the Naval Medical Center San Diego (NMCSD). Dr. Shumaker completed a Procedural Dermatology fellowship at Scripps Clinic in La Jolla, CA, and has since developed a special focus in Mohs surgery and laser medicine. Dr. Shumaker and colleagues have been dedicated to facilitating the functional and cosmetic recovery of wounded warriors and other patients with traumatic scarring and other related injuries. He has presented nationally and internationally on cutting edge scar management, co-authored articles published in top journals from 7 different medical specialties, led an annual national multidisciplinary Summit on trauma rehabilitation, served as team lead for a multi-year engagement in burn scar revision and restorative medicine in Vietnam, and served as co-Editor for The Scar Book published in 2017, the first comprehensive textbook on scar pathophysiology and management. He previously served on the Editorial Board for the Society publication Lasers in Surgery and Medicine. He continues his service to veterans as Chief of Dermatology at the VA San Diego and he is a non-salaried Clinical Professor at the University of California, San Diego.

Ray Choye
David Ozog, MD
Chair Department of Dermatology Henry Ford Health, Professor in Medicine Michigan State University
David M. Ozog, currently serves as Chair, Department of Dermatology and holds the C.S. Livingood Chair in Dermatology, at Henry Ford Hospital, Detroit, Michigan. He is also an active Mohs surgeon and Director of Cosmetic Dermatology. He received his undergraduate degree from the University of Michigan where he was a James B. Angell 4.0 GPA Scholar, completed post baccalaureate work at Bryn Mawr in Philadelphia and his medical degree from University of Rochester Medical School, Rochester, New York, where he was awarded AOA honors society. He completed his dermatology residency at Henry Ford Hospital, in Detroit, where he served as Chief Resident. His Mohs, Cosmetic and Procedural fellowship was with Dr. Ron Moy at UCLA Medical Center and Moy-Fincher Medical Group, in Beverly Hills, CA. He has published more than 90 articles and book chapters and has given hundreds of lectures nationally and internationally in various facets of procedural dermatology. His textbook, co-edited with Joel Cohen, Botulinum Toxins: Cosmetic and Clinical Applications, was published in 2017. Dr Ozog has directed sessions at the American Academy of Dermatology's annual meeting for several years. He was a member of the AAD coding committee, and he currently serves on the AAD Scientific Assembly Committee for a six-year term. He is scheduled to chair both Summer and Annual AAD meetings. He is also an editorial board member of JAMA Dermatology and an assistant editor of Dermatologic Surgery. His active research interests include cutaneous oncology, scarring prevention and treatment, botulinum toxins, as well as laser delivery for cosmetic and malignant conditions. He has trained more than 76 residents in dermatological surgery and was chosen by the residents as “Teacher of the Year.” Dr Ozog has taught hands on workshops nationally for the American Society for Dermatological Surgery, and he is co-director of the cadaver lab at Henry Ford. He enjoys biking and spending time with his wife Dawnmarie and their three children. Although his research group successfully pivoted to COVID work during the pandemic, he is thrilled to return to lasers and oncology, leaving spike proteins behind (hopefully forever).